Add BrightSurf on Google Email

Fast, accurate, low-cost diagnostics: No lab required

Researchers at Arizona State University have developed a rapid and accurate diagnostic test called NasRED that can detect diseases like COVID-19 with high sensitivity. The test uses tiny gold nanoparticles to identify disease-related proteins in a sample of bodily fluid, providing lab-quality accuracy without expensive equipment.

SourceArizona State University·JournalACS Nano·TypeExperimental study·DateAug 12, 2025

Medicare could save $3.6 billion without risk to older adults, study suggests

A new study published in JAMA Health Forum suggests that Medicare could save $3.6 billion annually by eliminating or reducing low-value tests and procedures for patients who do not benefit from them. This reduction in unnecessary care could also result in $800 million less in out-of-pocket costs for older adults.

SourceMichigan Medicine - University of Michigan·JournalJAMA Health Forum·TypeData/statistical analysis·DateAug 1, 2025

CNIO researcher develops a test aimed to detect early-stage tumors with a blood sample

Researchers developed a test to detect early-stage solid tumors using a blood sample, identifying patterns in amino acid concentrations that can translate into diagnostic signals. The test achieved an 87% positive rate and showed potential for precision medicine in choosing treatments.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalNature Communications·TypeExperimental study·DateJul 31, 2025

At-home melanoma testing with skin patch test

A new silicone patch with star-shaped microneedles, called the ExoPatch, distinguishes melanoma from healthy skin in mice, capturing cancer biomarkers from exosomes. The test shows promise for early detection of the most aggressive form of skin cancer without a biopsy or blood draw.

SourceUniversity of Michigan·JournalBiosensors and Bioelectronics·DateJul 28, 2025

Hepatitis C screening in emergency departments

A new study found that a nontargeted screening approach can identify more patients with hepatitis C virus infections than traditional targeted screening methods. The results highlight the need for improved treatment models, as patients who went from diagnosis to sustained virologic response increased significantly.

SourceJAMA Network·JournalJAMA·DateJul 9, 2025

Racial inequities and access to COVID-19 treatment

A cross-sectional study revealed racial disparities in COVID-19 treatment, with targeted interventions like expanding rapid test access and virtual care potentially improving equity. The findings suggest that encounter-level factors, such as differences in diagnostic test type and site of care, contribute to these inequities.

SourceJAMA Network·JournalJAMA Network Open·DateJul 1, 2025

Researchers solve ultrasound imaging problem using seismology technique

A team of scientists from Colorado State University and the University of São Paulo have developed a seismological solution to improve the resolution of ultrasound images for lung monitoring. This breakthrough could lead to improved critical care for patients, including continuous lung monitoring at the bedside. The technique uses seis...

SourceColorado State University·JournalIEEE Transactions on Biomedical Engineering·DateJun 11, 2025

New technology developed at the Lewis Katz School of Medicine at Temple University promises faster, earlier diagnosis of deadly form of heart failure

A novel screening approach called VEST uses virtual echocardiography to identify patients at high risk of pulmonary arterial hypertension, a life-threatening form of heart failure. The tool has been shown to generate accurate PAH risk scores without manual calculations and can guide timely referrals for expert care.

SourceTemple University Health System·JournalAmerican Heart Journal·DateJun 4, 2025

Making insulinomas a thing of the past

Researchers at Kyoto University have developed a new non-invasive diagnostic method for insulinomas, which achieved 100% diagnostic accuracy in a Phase II clinical trial. The new method using positron emission tomography (PET) probe successfully detected cases difficult to diagnose through existing methods.

SourceKyoto University·JournalThe Journal of Clinical Endocrinology & Metabolism·TypeRandomized controlled/clinical trial·DateMay 20, 2025

When doctors dismiss symptoms, patients suffer lasting harm

A review of 151 studies found that symptom invalidation can cause emotional states like self-doubt and shame, as well as behavioral changes such as avoiding medical care. The study recommends that healthcare providers validate patients' experiences, even in cases where a clear diagnosis cannot be made.

SourceRutgers University·JournalPsychological Bulletin·TypeMeta-analysis·DateMay 13, 2025

Simple test could better predict your risk of heart disease

Researchers found that measuring lipoprotein markers in a simple blood test can identify individuals at high risk of cardiovascular disease more effectively. The study analyzed data from over 200,000 people and showed that the total number of 'bad cholesterol' particles is the most important factor to consider when testing for future h...

SourceChalmers University of Technology·JournalEuropean Heart Journal·TypeObservational study·DateApr 28, 2025

SMART researchers develop novel UV and machine learning-aided method to detect microbial contamination in cell cultures

A new method using UV light and machine learning can detect microbial contamination in cell cultures, providing a quicker yes/no assessment within 30 minutes. This technology aims to reduce the time spent on sterility tests, making it crucial for life-saving treatments.

SourceSingapore-MIT Alliance for Research and Technology (SMART)·JournalScientific Reports·TypeExperimental study·DateApr 13, 2025

Mirvie announces results from largest molecular study in pregnancy and clinical validation of simple blood test to predict risk for preeclampsia months before symptoms

Researchers used data from 9,000 pregnancies to discover and validate RNA signatures that distinguish between severe and mild hypertensive disorders of pregnancy. The study validates Mirvie's simple blood test to predict preeclampsia early, at 17.5-22 weeks gestational age.

SourceMirvie·JournalNature Communications·TypeRandomized controlled/clinical trial·DateApr 8, 2025

Study: Platform-predicted treatments improve outcomes for platinum-resistant ovarian cancer

A Phase 3 trial found that ChemoID improves objective response rates, median progression-free survival, and duration of response in patients with recurrent platinum-resistant ovarian cancer. The test identifies effective treatments by challenging cancer stem cells against specific anticancer drugs.

SourceUniversity of Cincinnati·Journalnpj Precision Oncology·TypeRandomized controlled/clinical trial·DateApr 4, 2025